186 related articles for article (PubMed ID: 24400536)
1. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 5. Hepatic and gastrointestinal manifestations in collagen vascular diseases].
Shimoda S; Akahoshi M; Tsukamoto H
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2567-74. PubMed ID: 24400536
[No Abstract] [Full Text] [Related]
2. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 3. Pulmonary disease].
Kawashima M; Ohshima N; Kobayashi N
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2549-57. PubMed ID: 24400534
[No Abstract] [Full Text] [Related]
3. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 7. Vasculitis syndrome].
Okazaki T
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2582-90. PubMed ID: 24400538
[No Abstract] [Full Text] [Related]
4. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 6. Hematopoiesis].
Dobashi H; Kameda T
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2575-81. PubMed ID: 24400537
[No Abstract] [Full Text] [Related]
5. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 8. Skin and mucosa].
Fujimoto M
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2591-9. PubMed ID: 24400539
[No Abstract] [Full Text] [Related]
6. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 10. Eye].
Kawashima H
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2607-12. PubMed ID: 24400541
[No Abstract] [Full Text] [Related]
7. Gastrointestinal manifestations of collagen-vascular diseases.
Bassel K; Harford W
Semin Gastrointest Dis; 1995 Oct; 6(4):228-40. PubMed ID: 8528647
[No Abstract] [Full Text] [Related]
8. Shared autoimmunity: a concept for which the time has come.
Alarcón-Segovia D
Autoimmunity; 2005 May; 38(3):201-3. PubMed ID: 16126507
[No Abstract] [Full Text] [Related]
9. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Editorial: Autoimmunity, inflammation, and organ damage].
Ozaki S
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2529-31. PubMed ID: 24400531
[No Abstract] [Full Text] [Related]
10. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 3. Opportunistic infections].
Sumida K; Ubara Y
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2631-8. PubMed ID: 24400544
[No Abstract] [Full Text] [Related]
11. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 2. Cardiac involvement in connective tissue disease].
Hatano M
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2543-8. PubMed ID: 24400533
[No Abstract] [Full Text] [Related]
12. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: I. Damage to important organs whose early treatment makes a big difference; 4. Kidney].
Hiromura K
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2558-66. PubMed ID: 24400535
[No Abstract] [Full Text] [Related]
13. [Diffuse nephropathies in systemic diseases].
Tareev EM
Urol Nefrol (Mosk); 1970; 35(2):7-13. PubMed ID: 4394005
[No Abstract] [Full Text] [Related]
14. Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum?
Piga M; Vacca A; Porru G; Garau P; Cauli A; Mathieu A
Lupus; 2011 Nov; 20(13):1450-1. PubMed ID: 21951946
[No Abstract] [Full Text] [Related]
15. [Serious organ damage and intractable clinical conditions in rheumatic and connective tissue disease--progress in pathophysiology and treatment. Topics: II. Clinical conditions special attention needed to be paid to; 5. Pregnancy in autoimmune rheumatic diseases].
Murakawa Y
Nihon Naika Gakkai Zasshi; 2013 Oct; 102(10):2645-52. PubMed ID: 24400546
[No Abstract] [Full Text] [Related]
16. Hepatic manifestations of autoimmune rheumatic diseases.
Abraham S; Begum S; Isenberg D
Ann Rheum Dis; 2004 Feb; 63(2):123-9. PubMed ID: 14722198
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue diseases and the liver.
Youssef WI; Tavill AS
J Clin Gastroenterol; 2002 Oct; 35(4):345-9. PubMed ID: 12352299
[TBL] [Abstract][Full Text] [Related]
18. [Collagen diseases with gastrointestinal manifestations].
Takahashi H; Ohara M; Imai K
Nihon Rinsho Meneki Gakkai Kaishi; 2004 Jun; 27(3):145-55. PubMed ID: 15291251
[TBL] [Abstract][Full Text] [Related]
19. [Autoimmune diseases of the gastrointestinal tract and liver].
Warnatz H
Med Welt; 1970 May; 22():1025-9. PubMed ID: 5509752
[No Abstract] [Full Text] [Related]
20. Rheumatic diseases in children.
Spiera H
J Pediatr Ophthalmol Strabismus; 1982; 19(2):103-7. PubMed ID: 7201514
[No Abstract] [Full Text] [Related]
[Next] [New Search]
